Unique temporal and spatial expression patterns of IL-33 in ovaries during ovulation and estrous cycle are associated with ovarian tissue homeostasis

Journal of Immunology

Volumn 193, Issue 1, 2014, Pages 161-169

  Carlock, Colin I ^a   Wu, Jean ^a   Zhou, Cindy ^a,d   Tatum, Kiana ^a   Adams, Henry P ^b   Tan, Filemon ^c   Lou, Yahuan ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ESTRUS CYCLE; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HOMEOSTASIS; IL33 GENE; IMMUNE RESPONSE; IMMUNIZATION; MACROPHAGE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; OVARY CYCLE; OVARY FOLLICLE ATRESIA; PASSIVE TRANSPORT; PRIORITY JOURNAL; THECA CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ESTROUS CYCLE; FEMALE; FOLLICULAR ATRESIA; GENE EXPRESSION REGULATION; HOMEOSTASIS; INTERLEUKINS; MACROPHAGES; MICE; MICE, INBRED BALB C; NUCLEAR PROTEINS; OVARY; OVULATION; RNA, MESSENGER;

EID: 84903594513     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400381     Document Type: Article

References (40)

1. Baekkevold, E. S., M. Roussigné, T. Yamanaka, F. E. Johansen, F. L. Jahnsen, F. Amalric, P. Brandtzaeg, M. Erard, G. Haraldsen, and J. P. Girard. 2003. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 163: 69-79.
2. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
3. Liew, F. Y., N. I. Pitman, and I. B. McInnes. 2010. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10: 103-110.
4. Lingel, A., T. M. Weiss, M. Niebuhr, B. Pan, B. A. Appleton, C. Wiesmann, J. F. Bazan, and W. J. Fairbrother. 2009. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 17: 1398-1410.
5. Cayrol, C., and J. P. Girard. 2009. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 106: 9021-9026.
6. Lefrançais, E., S. Roga, V. Gautier, A. Gonzalez-de-Peredo, B. Monsarrat, J. P. Girard, and C. Cayrol. 2012. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. USA 109: 1673-1678.
7. Oboki, K., T. Ohno, N. Kajiwara, K. Arae, H. Morita, A. Ishii, A. Nambu, T. Abe, H. Kiyonari, K. Matsumoto, et al. 2010. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 107: 18581-18586.
8. Komai-Koma, M., D. Xu, Y. Li, A. N. J. McKenzie, I. B. McInnes, and F. Y. Liew. 2007. IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol. 37: 2779-2786.
9. Sponheim, J., J. Pollheimer, T. Olsen, J. Balogh, C. Hammarström, T. Loos, M. Kasprzycka, D. R. Sørensen, H. R. Nilsen, A. M. Küchler, et al. 2010. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am. J. Pathol. 177: 2804-2815.
10. Borish, L., and J. W. Steinke. 2011. Interleukin-33 in asthma: how big of a role does it play? Curr. Allergy Asthma Rep. 11: 7-11.
11. Bonilla, W. V., A. Fröhlich, K. Senn, S. Kallert, M. Fernandez, S. Johnson, M. Kreutzfeldt, A. N. Hegazy, C. Schrick, P. G. Fallon, et al. 2012. The alarmin interleukin-33 drives protective antiviral CD8+ T cell responses. Science 335: 984-989.
12. Enoksson, M., K. Lyberg, C. Möller-Westerberg, P. G. Fallon, G. Nilsson, and C. Lunderius-Andersson. 2011. Mast cells as sensors of cell injury through IL-33 recognition. J. Immunol. 186: 2523-2528.
13. Seki, K., S. Sanada, A. Y. Kudinova, M. L. Steinhauser, V. Handa, J. Gannon, and R. T. Lee. 2009. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ. Heart Fail. 2: 684-691.
14. Demyanets, S., C. Kaun, R. Pentz, K. A. Krychtiuk, S. Rauscher, S. Pfaffenberger, A. Zuckermann, A. Aliabadi, M. Gröger, G. Maurer, et al. 2013. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J. Mol. Cell. Cardiol. 60: 16-26.
15. Pichery, M., E. Mirey, P. Mercier, E. Lefrancais, A. Dujardin, N. Ortega, and J.-P. Girard. 2012. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J. Immunol. 188: 3488-3495.
16. Terranova, P. F., and V. M. Rice. 1997. Review: cytokine involvement in ovarian processes. Am. J. Reprod. Immunol. 37: 50-63.
17. Richards, J. S., D. L. Russell, S. Ochsner, and L. L. Espey. 2002. Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu. Rev. Physiol. 64: 69-92.
18. Clancy, K. B. H., A. R. Baerwald, and R. A. Pierson. 2013. Systemic inflammation is associated with ovarian follicular dynamics during the human menstrual cycle. PLoS ONE 8: e64807.
19. Spanel-Borowski, K. 2012. Follicular atresia as a proliferative and inflammatory event. In Atlas of the Mammalian Ovary: Morphological Dynamics and Potential Role of Innate Immunity. Springer p. 23-29.
20. Fukumatsu, Y., H. Katabuchi, M. Naito, M. Takeya, K. Takahashi, and H. Okamura. 1992. Effect of macrophages on proliferation of granulosa cells in the ovary in rats. J. Reprod. Fertil. 96: 241-249.
21. Wu, R., K. H. Van der Hoek, N. K. Ryan, R. J. Norman, and R. L. Robker. 2004. Macrophage contributions to ovarian function. Hum. Reprod. Update 10: 119-133.
22. Gaytán, F., C. Morales, C. Bellido, E. Aguilar, and J. E. Sánchez-Criado. 1998. Ovarian follicle macrophages: is follicular atresia in the immature rat a macrophage-mediated event? Biol. Reprod. 58: 52-59.
23. Brännström, M., G. Mayrhofer, and S. A. Robertson. 1993. Localization of leukocyte subsets in the rat ovary during the periovulatory period. Biol. Reprod. 48: 277-286.
24. Brännström, M., and R. J. Norman. 1993. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum. Reprod. 8: 1762-1775.
25. Carlock, C., J. Wu, C. Zhou, A. Ross, H. Adams, and Y. Lou. 2013. Ovarian phagocyte subsets and their distinct tissue distribution patterns. Reproduction 146: 491-500.
26. Zhou, C., J. Wu, J. Borillo, L. Torres, J. McMahon, and Y. H. Lou. 2009. Potential roles of a special CD8 α α+ cell population and CC chemokine thymusexpressed chemokine in ovulation related inflammation. J. Immunol. 182: 596-603.
27. Büscher, U., F. C. Chen, H. Kentenich, and H. Schmiady. 1999. Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction? Hum. Reprod. 14: 162-166.
28. Zhou, C., J. Borillo, J. Wu, L. Torres, and Y.-H. Lou. 2004. Ovarian expression of chemokines and their receptors. J. Reprod. Immunol. 63: 1-9.
29. Terranova, P. F. 1997. Potential roles of tumor necrosis factor-a in follicular development, ovulation, and the life span of the corpus luteum. Domest. Anim. Endocrinol. 14: 1-15.
30. Zhou, C., J. Wu, J. Borillo, L. Torres, J. McMahon, Y. Bao, and Y.-H. Lou. 2005. Transient expression of CC chemokine TECK in the ovary during ovulation: its potential role in ovulation. Am. J. Reprod. Immunol. 53: 238-248.
31. Machelon, V., and D. Emilie. 1997. Production of ovarian cytokines and their role in ovulation in the mammalian ovary. Eur. Cytokine Netw. 8: 137-143.
32. Byers, S. L., M. V. Wiles, S. L. Dunn, and R. A. Taft. 2012. Mouse estrous cycle identification tool and images. PLoS ONE 7: e35538.
33. Wong, K. H., H. Negishi, and E. Y. Adashi. 2002. Expression, hormonal regulation, and cyclic variation of chemokines in the rat ovary: key determinants of the intraovarian residence of representatives of the white blood cell series. Endocrinology 143: 784-791.
34. Sundlisaeter, E., R. J. Edelmann, J. Hol, J. Sponheim, A. M. Küchler, M. Weiss, I. A. Udalova, K. S. Midwood, M. Kasprzycka, and G. Haraldsen. 2012. The alarmin IL-33 is a notch target in quiescent endothelial cells. Am. J. Pathol. 181: 1099-1111.
35. Salker, M. S., J. Nautiyal, J. H. Steel, Z. Webster, S. Sućurović, M. Nicou, Y. Singh, E. S. Lucas, K. Murakami, Y.-W. Chan, et al. 2012. Disordered IL-33/ ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS ONE 7: e52252.
36. Yasuo, T., and K. Kitaya. 2009. Effect of ovarian steroids on gene expression profile in human uterine microvascular endothelial cells. Fertil. Steril. 92: 709-721.
37. Care, A. S., K. R. Diener, M. J. Jasper, H. M. Brown, W. V. Ingman, and S. A. Robertson. 2013. Macrophages regulate corpus luteum development during embryo implantation in mice. J. Clin. Invest. 123: 3472-3487.
38. Choi, Y. S., H. J. Choi, J. K. Min, B. J. Pyun, Y. S. Maeng, H. Park, J. Kim, Y. M. Kim, and Y. G. Kwon. 2009. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood 114: 3117-3126.
39. Choi, Y. S., J. A. Park, J. Kim, S. S. Rho, H. Park, Y. M. Kim, and Y. G. Kwon. 2012. Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation. Biochem. Biophys. Res. Commun. 421: 305-311.
40. Kaipia, A., and A. J. W. Hsueh. 1997. Regulation of ovarian follicle atresia. Annu. Rev. Physiol. 59: 349-363.